196 related articles for article (PubMed ID: 22173693)
1. Hepatocellular carcinoma: computed-tomography-guided high-dose-rate brachytherapy (CT-HDRBT) ablation of large (5-7 cm) and very large (>7 cm) tumours.
Collettini F; Schnapauff D; Poellinger A; Denecke T; Schott E; Berg T; Wust P; Hamm B; Gebauer B
Eur Radiol; 2012 May; 22(5):1101-9. PubMed ID: 22173693
[TBL] [Abstract][Full Text] [Related]
2. Unresectable colorectal liver metastases: percutaneous ablation using CT-guided high-dose-rate brachytherapy (CT-HDBRT).
Collettini F; Lutter A; Schnapauff D; Hildebrandt B; Puhl G; Denecke T; Wust P; Gebauer B
Rofo; 2014 Jun; 186(6):606-12. PubMed ID: 24407711
[TBL] [Abstract][Full Text] [Related]
3. CT-guided high-dose-rate brachytherapy of unresectable hepatocellular carcinoma.
Collettini F; Schreiber N; Schnapauff D; Denecke T; Wust P; Schott E; Hamm B; Gebauer B
Strahlenther Onkol; 2015 May; 191(5):405-12. PubMed ID: 25404063
[TBL] [Abstract][Full Text] [Related]
4. Computed-tomography-guided high-dose-rate brachytherapy (CT-HDRBT) ablation of metastases adjacent to the liver hilum.
Collettini F; Singh A; Schnapauff D; Powerski MJ; Denecke T; Wust P; Hamm B; Gebauer B
Eur J Radiol; 2013 Oct; 82(10):e509-14. PubMed ID: 23791521
[TBL] [Abstract][Full Text] [Related]
5. Primary and metastatic malignancies of the lung: Retrospective analysis of the CT-guided high-dose rate brachytherapy (CT-HDRBT) ablation in tumours <4 cm and ≥4 cm.
Jonczyk M; Collettini F; Schnapauff D; Geisel D; Böning G; Feldhaus F; Wieners G; Hamm B; Gebauer B
Eur J Radiol; 2018 Nov; 108():230-235. PubMed ID: 30396661
[TBL] [Abstract][Full Text] [Related]
6. Initial Experience with CT-Guided High-Dose-Rate Brachytherapy in the Multimodality Treatment of Neuroendocrine Tumor Liver Metastases.
Schippers AC; Collettini F; Steffen IG; Wieners G; Denecke T; Pavel M; Wust P; Gebauer B
J Vasc Interv Radiol; 2017 May; 28(5):672-682. PubMed ID: 27645463
[TBL] [Abstract][Full Text] [Related]
7. Cholangiocarcinoma: CT-guided High-Dose Rate Brachytherapy (CT-HDRBT) for Limited (<4 cm) and Large (>4 cm) Tumors.
Jonczyk M; Collettini F; Schnapauff D; Geisel D; Böning G; Feldhaus F; Denecke T; Wieners G; Hamm B; Gebauer B
Anticancer Res; 2018 Oct; 38(10):5843-5852. PubMed ID: 30275209
[TBL] [Abstract][Full Text] [Related]
8. Treatment for liver metastasis from renal cell carcinoma with computed-tomography-guided high-dose-rate brachytherapy (CT-HDRBT): a case series.
Geisel D; Collettini F; Denecke T; Grieser C; Flörcken A; Wust P; Hamm B; Gebauer B
World J Urol; 2013 Dec; 31(6):1525-30. PubMed ID: 23132612
[TBL] [Abstract][Full Text] [Related]
9. Activity-based cost analysis of hepatic tumor ablation using CT-guided high-dose rate brachytherapy or CT-guided radiofrequency ablation in hepatocellular carcinoma.
Schnapauff D; Collettini F; Steffen I; Wieners G; Hamm B; Gebauer B; Maurer MH
Radiat Oncol; 2016 Feb; 11():26. PubMed ID: 26911437
[TBL] [Abstract][Full Text] [Related]
10. CT-guided brachytherapy as salvage therapy for intrahepatic recurrence of HCC after surgical resection.
Schnapauff D; Collettini F; Hartwig K; Wieners G; Chopra S; Hamm B; Gebauer B
Anticancer Res; 2015 Jan; 35(1):319-23. PubMed ID: 25550566
[TBL] [Abstract][Full Text] [Related]
11. CT-guided high-dose-rate brachytherapy in the interdisciplinary treatment of patients with liver metastases of pancreatic cancer.
Wieners G; Schippers AC; Collettini F; Schnapauff D; Hamm B; Wust P; Riess H; Gebauer B
Hepatobiliary Pancreat Dis Int; 2015 Oct; 14(5):530-8. PubMed ID: 26459730
[TBL] [Abstract][Full Text] [Related]
12. CT-guided high-dose-rate brachytherapy of liver tumours does not impair hepatic function and shows high overall safety and favourable survival rates.
Brinkhaus G; Lock JF; Malinowski M; Denecke T; Neuhaus P; Hamm B; Gebauer B; Stockmann M
Ann Surg Oncol; 2014 Dec; 21(13):4284-92. PubMed ID: 24934583
[TBL] [Abstract][Full Text] [Related]
13. Computed tomography-guided iodine-125 brachytherapy for unresectable hepatocellular carcinoma.
Song Z; Ye J; Wang Y; Li Y; Wang W
J Cancer Res Ther; 2019; 15(7):1553-1560. PubMed ID: 31939437
[TBL] [Abstract][Full Text] [Related]
14. Computed tomography-guided interstitial HDR brachytherapy (CT-HDRBT) of the liver in patients with irresectable intrahepatic cholangiocarcinoma.
Schnapauff D; Denecke T; Grieser C; Collettini F; Seehofer D; Sinn M; Banzer J; Lopez-Hänninen E; Hamm B; Wust P; Gebauer B
Cardiovasc Intervent Radiol; 2012 Jun; 35(3):581-7. PubMed ID: 21833806
[TBL] [Abstract][Full Text] [Related]
15. Percutaneous ablation of lymph node metastases using CT-guided high-dose-rate brachytherapy.
Collettini F; Schippers AC; Schnapauff D; Denecke T; Hamm B; Riess H; Wust P; Gebauer B
Br J Radiol; 2013 Jul; 86(1027):20130088. PubMed ID: 23659925
[TBL] [Abstract][Full Text] [Related]
16. Interstitial Brachytherapy in Combination With Previous Transarterial Embolization in Patients With Unresectable Hepatocellular Carcinoma.
Schnapauff D; Tegel BR; Powerski MJ; Colletini F; Hamm B; Gebauer B
Anticancer Res; 2019 Mar; 39(3):1329-1336. PubMed ID: 30842165
[TBL] [Abstract][Full Text] [Related]
17. [Percutaneous CT-guided high-dose brachytherapy (CT-HDRBT) ablation of primary and metastatic lung tumors in nonsurgical candidates].
Collettini F; Schnapauff D; Poellinger A; Denecke T; Banzer J; Golenia MJ; Wust P; Gebauer B
Rofo; 2012 Apr; 184(4):316-23. PubMed ID: 22297915
[TBL] [Abstract][Full Text] [Related]
18. Treatment of hepatic metastases from gastric or gastroesophageal adenocarcinoma with computed tomography-guided high-dose-rate brachytherapy (CT-HDRBT).
Geisel D; Denecke T; Collettini F; Grieser C; Wust P; Thuss-Patience P; Hamm B; Gebauer B
Anticancer Res; 2012 Dec; 32(12):5453-8. PubMed ID: 23225451
[TBL] [Abstract][Full Text] [Related]
19. Percutaneous computed tomography-guided high-dose-rate brachytherapy ablation of breast cancer liver metastases: initial experience with 80 lesions.
Collettini F; Golenia M; Schnapauff D; Poellinger A; Denecke T; Wust P; Riess H; Hamm B; Gebauer B
J Vasc Interv Radiol; 2012 May; 23(5):618-26. PubMed ID: 22525020
[TBL] [Abstract][Full Text] [Related]
20. Combined CT-guided high-dose-rate brachytherapy (CT-HDRBT) and transarterial chemoembolization with irinotecan-loaded microspheres improve local tumor control and progression-free survival in patients with unresectable colorectal liver metastases compared with mono-CT-HDRBT.
Friedrich S; Busch F; Jonczyk M; Wieners G; Böning G; Lüdemann WM; Meddeb A; Collettini F; Gebauer B
J Contemp Brachytherapy; 2023 Feb; 15(1):15-26. PubMed ID: 36970444
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
